Abstract
Breast cancer is the leading cause of cancer mortality in women. The creation of accessible, accurate and fast biomarkers panels that allow the refining of the prognosis of these patients to better allocate the therapeutic resources is fundamental to increase the curability of this disease in its early stages before the development of detectable metastases by imaging methods. Methods that…